Discover Every Possible Payment Source
To continue to innovate as the original, preeminent provider of Complex Third-Party Liability (TPL) and Mass Tort / Multidistrict Litigation (MDL) Discovery Analytics within the U.S. Healthcare Delivery System, providing TPL and MDL discovery analytics and related business intelligence to the communities serving the healthcare provider and self-insured employer verticals.
As a trusted source of meaningful Complex Third-Party Liability (TPL) and Mass Tort Multidistrict Litigation (MDL) Discovery Analytics and related business intelligence, become a conduit for recovery optimization and related expense reduction to help U.S. healthcare providers and self-insured employer-sponsored health plans meet their respective financial goals and objectives.
Discover Claims has developed a proprietary suite of Complex TPL Discovery Analytics® that can be applied to a hospital’s current and legacy uncollected accounts data to reveal these legal actions, related activities, and payment sources. This unique technology can be applied in a variety of ways:
Discover Claims’ proprietary Complex TPL Discovery Analytics® deploys sophisticated machine learning across a variety of large, disparate data sources to reveal unknown third-party payment sources within a health system’s written off Accounts Receivables. These third-party payment sources can be categorized by degree of difficulty to monetize:
Most healthcare systems are leaving significant revenue on the table every year by failing to exercise their legal recovery rights related to multidistrict litigations(“MDLs”). MDL verdicts and settlements are “lienable events” which enables a hospital to file alien to recover monies owed for care provided but not reimbursed relatable to the MDL in which the patient is a claimant. Many MDLs have six-figure average settlement values.
Complex MDL Discovery Analytics® identifies potential MDL revenue by using algorithms to discover existing MDL claimants in active litigations for which the hospital or healthcare system may file a lien. MDLs are specifically designed for multiple litigations from different jurisdictions with similar injuries and exposures are consolidated in a federal district or filed in state courts to efficiently manage cases. Unlike class action litigations, if an MDL case results in a verdict or settlement, each plaintiff is compensated according to their individual damages. MDL verdicts and settlements are “lienable” events for healthcare systems.
MDLs arise when drug, medical device and consumer products manufacturers fail to take proper precautions to safeguard the public, resulting in similar illness or bodily harm to large victim pools. MDLs typically involve allegations against the manufacturers due to “failure to warn,” or deceptive marketing allegations. Common issues of use/exposure and injuries are present for each MDL. Cases do not incur professional or hospital liability; the named defendants are the manufacturers of the applicable medical device, consumer product, or pharmaceutical.
Healthcare-centric MDLs refer specifically to those causes of action which are relatable to injuries alleged to have arisen from exposure to a defective drug, medical device, or consumer product.
Are paid by the manufacturer (defendant) and can be facilitated on a ‘global’ or ‘inventory’ basis: block settlements with law firms that represent a large numbers of specific MDL cases. Most MDLs maintain a Private Lien Holdback set aside embedded within the structure of the settlement, designed to specifically respond to financial lien obligations (e.g., billed charges that sit behind the uncompensated care related to treating a patient’s injuries related to the MDL for which a provider has a right to recover). Private lien holdbacks are typically valued at 25% to 35% of the Average Settlement Value.
.jpg)
